By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Angiography is favoured in minimally invasive operations because angiograms obtained during the diagnostic phase give a thorough, clear, and correct image of the blood arteries in a patient’s heart, reducing the need for costly invasive surgery.
As a result of this, medical professionals are increasingly preferring minimally invasive surgical techniques over traditional open operations due to the clinical and financial advantages provided by the former. As a result, the market for angiography equipment is expanding.
One of the primary reasons expected to fuel the growth of the angiography equipment market during the projected period is the growing prevalence of cancer and cardiovascular illnesses worldwide.
The North America Angiography Devices Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
GE Healthcare not only unveiled dozens of new digital solutions to improve patient screening, diagnostics, treatment, and monitoring at the Radiological Society of North America’s ongoing annual meeting but also highlighted several AI-powered technologies that the company has debuted in recent months.
Critical Care Suite 2.0 is the most recent of these, an AI platform installed on mobile X-ray equipment to autonomously compute measurements during scans, triage cases, and manage quality standards.
One of the AI algorithms in the suite was the first to be approved by the FDA to assist doctors in assessing endotracheal tube placements earlier this month.GE also emphasised its Allia platform, which serves as AI-powered assistance during image-guided therapeutic operations.
The technology works around clinicians to place a laser-guided robotic arm autonomously and uses augmented reality to improve its direction during surgery.
